201. Impact of beta-blocker therapy on thoracic aorta 3D wall shear stress in patients with bicuspid aortic valve
- Author
-
Bradley D. Allen, Michael Markl, Preeti Kansal, Jeremy D. Collins, Pim van Ooij, James C. Carr, and Alex J. Barker
- Subjects
Medicine(all) ,medicine.medical_specialty ,Radiological and Ultrasound Technology ,business.industry ,Beta blocker therapy ,medicine.disease ,3. Good health ,Aortic aneurysm ,Bicuspid aortic valve ,Internal medicine ,medicine.artery ,Ascending aorta ,cardiovascular system ,medicine ,Shear stress ,Cardiology ,Oral Presentation ,Thoracic aorta ,Radiology, Nuclear Medicine and imaging ,In patient ,Cardiology and Cardiovascular Medicine ,business ,circulatory and respiratory physiology ,Angiology - Abstract
Background Beta-blockers are the recommended medical treatment for slowing ascending aorta (AAo) dilation in patients with bicuspid aortic valve (BAV). Wall shear stress (WSS) has been shown to promote endothelial cell dysfunction [1] and AAo WSS may play a role in aortic aneurysm growth. Time-resolved 3D phase contrast (4D flow) MRI allows for the quantification of 3D WSS regionally in the thoracic aorta. The aim of this study was to assess changes in thoracic aorta WSS associated with b-blocker therapy in BAV patients.
- Published
- 2014
- Full Text
- View/download PDF